TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CEFTAROLINE FOSAMIL

CEFTAROLINE FOSAMIL
Infectious Disease Approved 2021-09-21
1
Indication
--
Phase 3 Trials
4
Years on Market

Details

Status
Prescription
First Approved
2021-09-21
Routes
INTRAVENOUS
Dosage Forms
POWDER

Companies

Active Ingredient: CEFTAROLINE FOSAMIL

CEFTAROLINE FOSAMIL Approval History

Loading approval history...

What CEFTAROLINE FOSAMIL Treats

2 indications

CEFTAROLINE FOSAMIL is approved for 2 conditions since its original approval in 2021. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Acute Bacterial Skin and Skin Structure Infections
  • Community-Acquired Bacterial Pneumonia
Source: FDA Label
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CEFTAROLINE FOSAMIL FDA Label Details

Pro

Indications & Usage

Ceftaroline fosamil for injection is a cephalosporin antibacterial indicated in adult and pediatric patients for the treatment of the following infection caused by designated susceptible bacteria: Acute bacterial skin and skin structure infections (ABSSSI) in adult and pediatric patients (at least 34 weeks gestational age and 12 days postnatal age) Community-acquired bacterial pneumonia (CABP) in adult and pediatric patients 2 months of age and older To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftaroline fosamil for injection and other antibacterial ...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.